JAHA:酒渣鼻患者要注意心血管疾病风险

2021-09-24 MedSci原创 MedSci原创

这项研究表明酒渣鼻患者更容易发生心血管疾病。需要对酒渣鼻患者进行适当的教育,以处理其他可改变的CVD危险因素。

越来越多的证据表明,酒渣鼻是一种慢性皮肤炎症性疾病,与各种全身性疾病有关。然而,其与血管疾病(CVD)之间的关联仍存在争议。

近日,心血管疾病领域权威杂志JAHA上发表了一篇研究文章,研究人员旨在调查酒渣鼻患者患心血管疾病的风险是否增加。

这项来自韩国国民健康保险服务健康筛查队列的回顾性队列研究纳入了2003年至2014年期间新诊断的酒渣鼻患者(n=2681)和年龄、性别和年份匹配的无酒渣鼻对照人群(n=26810)。该研究的主要结局是随后的CVD,包括冠心病和卒中。多变量Cox回归分析用于评估后续CVD调整后的风险比。

与对照人群(13410名女性;平均[SD]年龄为57.7[9.2]岁)相比,酒渣鼻患者(1341名女性;平均[SD]年龄为57.7[9.2]岁)的CVD(调整后的风险比为1.20;95%CI为1.03-1.40)和冠心病(调整后的风险比为1.29;95%CI为1.05-1.60)的风险增加。卒中风险并未显著升高(调整后的风险比为1.12;95%CI为0.91-1.37)。

这项研究表明酒渣鼻患者更容易发生心血管疾病。需要对酒渣鼻患者进行适当的教育,以处理其他可改变的CVD危险因素。

原始出处:

Daein Choi.et al.Association of Rosacea With Cardiovascular Disease: A Retrospective Cohort Study.JAHA.2021.https://www.ahajournals.org/doi/10.1161/JAHA.120.020671

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1241751, encodeId=52a01241e5120, content=<a href='/topic/show?id=03cf954668b' target=_blank style='color:#2F92EE;'>#酒渣鼻#</a>患者要注意<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95466, encryptionId=03cf954668b, topicName=酒渣鼻), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Aug 29 03:07:04 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057097, encodeId=6508105e09752, content=恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a302278293, createdName=121bd5e0m05暂无昵称, createdTime=Sun Oct 03 13:21:03 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268633, encodeId=e96d1268633eb, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473292, encodeId=4c5514e329296, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498941, encodeId=ab7114989413e, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054605, encodeId=4304105460577, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/8210ada76f0842e588208f7816b563ae/7ef8aeed6bc94c48853528fb1f5cb54b.jpg, createdBy=72325568932, createdName=法荣, createdTime=Sat Sep 25 02:56:01 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054544, encodeId=9ad61054544e4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Fri Sep 24 20:58:20 CST 2021, time=2021-09-24, status=1, ipAttribution=)]
    2022-08-29 循证小兵
  2. [GetPortalCommentsPageByObjectIdResponse(id=1241751, encodeId=52a01241e5120, content=<a href='/topic/show?id=03cf954668b' target=_blank style='color:#2F92EE;'>#酒渣鼻#</a>患者要注意<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95466, encryptionId=03cf954668b, topicName=酒渣鼻), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Aug 29 03:07:04 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057097, encodeId=6508105e09752, content=恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a302278293, createdName=121bd5e0m05暂无昵称, createdTime=Sun Oct 03 13:21:03 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268633, encodeId=e96d1268633eb, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473292, encodeId=4c5514e329296, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498941, encodeId=ab7114989413e, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054605, encodeId=4304105460577, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/8210ada76f0842e588208f7816b563ae/7ef8aeed6bc94c48853528fb1f5cb54b.jpg, createdBy=72325568932, createdName=法荣, createdTime=Sat Sep 25 02:56:01 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054544, encodeId=9ad61054544e4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Fri Sep 24 20:58:20 CST 2021, time=2021-09-24, status=1, ipAttribution=)]
    2021-10-03 121bd5e0m05暂无昵称

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1241751, encodeId=52a01241e5120, content=<a href='/topic/show?id=03cf954668b' target=_blank style='color:#2F92EE;'>#酒渣鼻#</a>患者要注意<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95466, encryptionId=03cf954668b, topicName=酒渣鼻), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Aug 29 03:07:04 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057097, encodeId=6508105e09752, content=恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a302278293, createdName=121bd5e0m05暂无昵称, createdTime=Sun Oct 03 13:21:03 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268633, encodeId=e96d1268633eb, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473292, encodeId=4c5514e329296, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498941, encodeId=ab7114989413e, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054605, encodeId=4304105460577, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/8210ada76f0842e588208f7816b563ae/7ef8aeed6bc94c48853528fb1f5cb54b.jpg, createdBy=72325568932, createdName=法荣, createdTime=Sat Sep 25 02:56:01 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054544, encodeId=9ad61054544e4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Fri Sep 24 20:58:20 CST 2021, time=2021-09-24, status=1, ipAttribution=)]
    2021-09-26 zhaohui6731
  4. [GetPortalCommentsPageByObjectIdResponse(id=1241751, encodeId=52a01241e5120, content=<a href='/topic/show?id=03cf954668b' target=_blank style='color:#2F92EE;'>#酒渣鼻#</a>患者要注意<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95466, encryptionId=03cf954668b, topicName=酒渣鼻), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Aug 29 03:07:04 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057097, encodeId=6508105e09752, content=恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a302278293, createdName=121bd5e0m05暂无昵称, createdTime=Sun Oct 03 13:21:03 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268633, encodeId=e96d1268633eb, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473292, encodeId=4c5514e329296, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498941, encodeId=ab7114989413e, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054605, encodeId=4304105460577, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/8210ada76f0842e588208f7816b563ae/7ef8aeed6bc94c48853528fb1f5cb54b.jpg, createdBy=72325568932, createdName=法荣, createdTime=Sat Sep 25 02:56:01 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054544, encodeId=9ad61054544e4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Fri Sep 24 20:58:20 CST 2021, time=2021-09-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1241751, encodeId=52a01241e5120, content=<a href='/topic/show?id=03cf954668b' target=_blank style='color:#2F92EE;'>#酒渣鼻#</a>患者要注意<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95466, encryptionId=03cf954668b, topicName=酒渣鼻), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Aug 29 03:07:04 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057097, encodeId=6508105e09752, content=恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a302278293, createdName=121bd5e0m05暂无昵称, createdTime=Sun Oct 03 13:21:03 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268633, encodeId=e96d1268633eb, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473292, encodeId=4c5514e329296, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498941, encodeId=ab7114989413e, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054605, encodeId=4304105460577, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/8210ada76f0842e588208f7816b563ae/7ef8aeed6bc94c48853528fb1f5cb54b.jpg, createdBy=72325568932, createdName=法荣, createdTime=Sat Sep 25 02:56:01 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054544, encodeId=9ad61054544e4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Fri Sep 24 20:58:20 CST 2021, time=2021-09-24, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1241751, encodeId=52a01241e5120, content=<a href='/topic/show?id=03cf954668b' target=_blank style='color:#2F92EE;'>#酒渣鼻#</a>患者要注意<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95466, encryptionId=03cf954668b, topicName=酒渣鼻), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Aug 29 03:07:04 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057097, encodeId=6508105e09752, content=恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a302278293, createdName=121bd5e0m05暂无昵称, createdTime=Sun Oct 03 13:21:03 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268633, encodeId=e96d1268633eb, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473292, encodeId=4c5514e329296, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498941, encodeId=ab7114989413e, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054605, encodeId=4304105460577, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/8210ada76f0842e588208f7816b563ae/7ef8aeed6bc94c48853528fb1f5cb54b.jpg, createdBy=72325568932, createdName=法荣, createdTime=Sat Sep 25 02:56:01 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054544, encodeId=9ad61054544e4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Fri Sep 24 20:58:20 CST 2021, time=2021-09-24, status=1, ipAttribution=)]
    2021-09-25 法荣

    学习学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1241751, encodeId=52a01241e5120, content=<a href='/topic/show?id=03cf954668b' target=_blank style='color:#2F92EE;'>#酒渣鼻#</a>患者要注意<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95466, encryptionId=03cf954668b, topicName=酒渣鼻), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Aug 29 03:07:04 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057097, encodeId=6508105e09752, content=恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a302278293, createdName=121bd5e0m05暂无昵称, createdTime=Sun Oct 03 13:21:03 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268633, encodeId=e96d1268633eb, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473292, encodeId=4c5514e329296, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498941, encodeId=ab7114989413e, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sun Sep 26 11:23:20 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054605, encodeId=4304105460577, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/8210ada76f0842e588208f7816b563ae/7ef8aeed6bc94c48853528fb1f5cb54b.jpg, createdBy=72325568932, createdName=法荣, createdTime=Sat Sep 25 02:56:01 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054544, encodeId=9ad61054544e4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Fri Sep 24 20:58:20 CST 2021, time=2021-09-24, status=1, ipAttribution=)]
    2021-09-24 zerohahaha

    学习了

    0

相关资讯

JCEM:MAFLD与糖尿病、慢性肾病和心血管疾病的关联

从NAFLD到MAFLD的变化对其与糖尿病、CKD和CVD之间的关联没有太大影响。采用MAFLD定义进一步确定了代谢性脂肪肝合并过度饮酒和HBV感染的患者,与非脂肪肝患者相比,发生糖尿病的风险增加。

JADV:斑秃患者的心血管和代谢疾病患病率分析

斑秃(AA)是一种自身免疫性疾病,可出现无疤痕的脱发斑块。和其他自身免疫性疾病与心血管和代谢性疾病的风险增加相关,该文分析了AA型患者的心脏和代谢疾病的患病率。

Heart:碳水化合物和饱和脂肪摄入量与女性心血管疾病和死亡率的关系

适度的碳水化合物摄入量(TEI为41.0%–44.3%)与最低的CVD风险相关,但对总死亡率没有影响。增加饱和脂肪摄入量与心血管疾病或死亡率无关,而是与较低的糖尿病、高血压和肥胖率相关。

BMC Cancer:制定复查计划时要留心!乳腺癌患者应着重预防哪些心血管疾病?

这项来自丹麦的全国性队列研究指出,在BC患者确诊6年内所有 CVD 发生率都显著增高,在10年随访期内心力衰竭、血栓炎/血栓形成和肺心脏病风险仍较普通人群高。

北京疾控和卫健委联合发布:PM2.5污染越重,心血管疾病住院风险越高!

PM2.5 浓度越高、重度 PM2.5 污染事件持续时间越长,心血管疾病住院风险就越大

50万人数据:预防心肌代谢性疾病只能看DASH和地中海饮食?中国饮食模式也能!

50万中国成年人的饮食模式与心脏代谢疾病:一项10年队列研究!